Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27717303

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2016 Nov 3
First author
Hortobagyi GN

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jan 19;376(3):289. doi: 10.1056/NEJMc1615255.
    note
    Source null
    related pmid
    28099830
    relationship
    Comment in
  2. citation
    N Engl J Med. ;376(3):288. doi: 10.1056/NEJMc1615255.
    note
    Source null
    related pmid
    28102647
    relationship
    Comment in
  3. citation
    N Engl J Med. ;376(3):288-289. doi: 10.1056/NEJMc1615255.
    note
    Source null
    related pmid
    28102649
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Dec 27;379(26):2582. doi: 10.1056/NEJMx180043.
    note
    Source null
    related pmid
    30586508
    relationship
    Erratum in

Authors and identifiers

  1. name
    Hortobagyi GN
    type
    Author
  2. name
    Stemmer SM
    type
    Author
  3. name
    Burris HA
    type
    Author
  4. name
    Yap YS
    type
    Author
  5. name
    Sonke GS
    type
    Author
  6. name
    Paluch-Shimon S
    type
    Author
  7. name
    Campone M
    type
    Author
  8. name
    Blackwell KL
    type
    Author
  9. name
    André F
    type
    Author
  10. name
    Winer EP
    type
    Author
  11. name
    Janni W
    type
    Author
  12. name
    Verma S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hortobagyi GN
    type
    Author
  2. name
    Stemmer SM
    type
    Author
  3. name
    Burris HA
    type
    Author
  4. name
    Yap YS
    type
    Author
  5. name
    Sonke GS
    type
    Author
  6. name
    Paluch-Shimon S
    type
    Author
  7. name
    Campone M
    type
    Author
  8. name
    Blackwell KL
    type
    Author
  9. name
    André F
    type
    Author
  10. name
    Winer EP
    type
    Author
  11. name
    Janni W
    type
    Author
  12. name
    Verma S
    type
    Author
bibliography ids
  1. nci-bib-10fb0d8479df7ee8077662b8
book metadata
content sha256
04379a5e011f1ea311426ab187d6518d5a58068cefe422c4ed4769f1397166e3
document type
citation
dois
  1. 10.1056/NEJMoa1609709
electronic publication date
display
2016 Oct 7
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27717303
immutable id
pubmed:27717303@04379a5e011f1ea311426ab187d6518d5a58068cefe422c4ed4769f1397166e3
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
18
name
The New England journal of medicine
nlm unique id
0255562
pages
1738-1748
volume
375
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jan 19;376(3):289. doi: 10.1056/NEJMc1615255.
    note
    Source null
    related pmid
    28099830
    relationship
    Comment in
  2. citation
    N Engl J Med. ;376(3):288. doi: 10.1056/NEJMc1615255.
    note
    Source null
    related pmid
    28102647
    relationship
    Comment in
  3. citation
    N Engl J Med. ;376(3):288-289. doi: 10.1056/NEJMc1615255.
    note
    Source null
    related pmid
    28102649
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Dec 27;379(26):2582. doi: 10.1056/NEJMx180043.
    note
    Source null
    related pmid
    30586508
    relationship
    Erratum in
outcomes validated
false
pmid
27717303
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
9aa04761310acee3165ba2bd7f12d6bb25e191b72079b2d8e527baa3a8394423
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Nov 3
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27717303/
title
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Preserved source evidence · Not medical advice